
Olink® — Part of Thermo Fisher Scientific
Today, we announced the launch of the Olink® Target 48 Neurodegeneration Panel – a high-performance, targeted proteomics immunoassay panel designed to accelerate discoveries in …
About Olink — Olink®
Olink’s mission is to accelerate proteomics together with the scientific community, to understand real-time biology and gain actionable insights into human health and disease.
Olink Explore HT — Olink®
Olink Explore HT is designed for outstanding performance at any scale of protein biomarker discovery, from tens to millions of samples. This scalability is enabled by a streamlined, automated workflow …
What is PEA? — Olink®
Olink is one of the world’s most trusted next-generation proteomics platforms. Our technology uncovers the truth of real-time biology, empowering innovative startups, small research labs, and leading …
Olink® Target series
Olink® Target series Our Target series focuses on targeted protein panels with high specificity and sensitivity, enabling researchers to study selected proteins with precision in various sample types.
Olink® Explore series
Olink® Explore series Our Explore series offers high-throughput proteomics, analyzing thousands of proteins simultaneously with exceptional specificity and scalability, enabling advanced disease …
Olink Insight — Olink®
Bring your biomarker lists into Olink Insight. You can overlay annotation data like disease risk associations, tissue specificity, pathway information, biological processes, and drug target …
Olink Flex — Olink®
Olink’s scalable technology provides optimized solutions for every stage of the biomarker workflow, from high-throughput discovery through validation and clinical utility.
Compare our products — Olink®
Next-generation high-throughput proteomics empowers genetically-informed assessment of protein causality and the confident identification of novel drug targets. Join the growing global community …
Products — Olink®
Next-generation high-throughput proteomics empowers genetically-informed assessment of protein causality and the confident identification of novel drug targets. Join the growing global community …